- Benicar Litigation
- Da Vinci Robotic Hysterectomy Lawsuits
- DePuy Hip Replacement Implants
- Essure Birth Control Device
- Medtronic Insulin Pump and Infusion Set
- Medtronic SynchroMed II Infusion Pumps
- Morcellator Lawsuit
The U.S. Food and Drug Administration (FDA) oversees drugs and medical devices that are released on the market. Manufacturers are required to go through a rigorous and comprehensive testing process before each pharmaceutical drug or device is approved for human consumption.
Manufacturers develop these drugs and devices with the intention of providing patients with safe and effective treatment options for what can be serious medical problems. And most times, for most people, they do just that.
Unfortunately, sometimes drugs and devices have not been properly tested or manufactured. When this occurs, severe side effects, irreparable health consequences, or even death can be the result. Even after a defective drug or device is found to cause medical problems, they can remain on the market for a period of time before being recalled, causing a significant number of injuries or deaths.
Drug manufacturers have a duty to warn users of the risks associated with each medication. If they fail to warn the public, they can be held liable for serious medical conditions that are not known to the consumer.
The lawyers at Ashcraft & Gerel have been leaders in medical product liability lawsuits involving unsafe drugs, implants, and other devices. The firm has a team of more than 20 lawyers, paralegals and medical professionals dedicated full-time to pursuing justice for those harmed by dangerous drugs and medical devices. Our attorneys have successfully won verdicts, settlements, awards, and other recoveries in lawsuits on behalf of clients who have been injured by Zyprexa, Fen-Phen, Rezulin, Propulsid, Phenylpropanolamine (PPA), breast implants, and AIDS-tainted blood.
Although some of these claims and lawsuits have resulted in class action settlements, class actions are not the only way these cases are handled. On March 22, 2013, Ashcraft & Gerel attorneys won a $5 million verdict on behalf of an individual client against manufacturer General Electric, for failure to warn patients and providers of the serious risks arising from its CT scan dye, Omniscan.
Contact Our Team of Pharmaceutical and Medical Device Attorneys Today
If you or a family member think you may have been harmed by a dangerous drug or medical device, contact one of our attorneys today to review your legal rights. Ashcraft & Gerel reviews each case on an individual basis to determine the best course of action for each client. Call or email us today to discuss your experience.